2021 Update on LN, RA & COVID-19: Is Voclosporin a New Big Addition to Lupus Treatment Arsenal? Are RA-ILD Patients at Higher Mortality Risk? Is Benlysta Therapy Safe With COVID-19 Vaccine?

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

2021 Update on LN, RA & COVID-19: Is Voclosporin a New Big Addition to Lupus Treatment Arsenal? Are RA-ILD Patients at Higher Mortality Risk? Is Benlysta Therapy Safe With COVID-19 Vaccine?

By RheumNow FEATURING John J. Cush

203 views

January 28, 2021

Comments 0

Are your patients with moderate to severe Rheumatoid Arthritis (RA) …

Feat. O. Troum, A. Wells, A. Broadwell, G. Wright

Systemic Sclerosis-Associated Interstitial Lung Disease: A Patient&#…

Feat. E. Volkmann

Long COVID & Post-Viral Syndromes ECHO Series 2025

Wed, Jan 1, 2025

RheumNow News Highlights: 11 Agents That Cause Arthritis, Lupus - Te…

RheumNow

J. Cush

1.0K views

Dermatology-Rheumatology Grand Rounds: The Whole Is Greater Than the…

University of Colorado Department of Medicine

E. Wallace, J. Zell

663 views

New

Walking Pneumonia, the Beginning of Influenza Season, and Does Antiv…

MicrobeTV

D. Griffin, V. Racaniello

1.1K views

Clinical Approach to Diagnosis and Treatment of Cytokine Storm in Rh…

Cleveland Clinic Rheumatology

R. Q. Cron

318 views

What to Know About the FDA Authorization and Approval of Updated COV…

Amesh Adalja

3.9K views

Checkpoint Inhibitors, Arthritis and Other Autoimmune Triggers

West Virginia State Rheumatology Society

J. Bustamante

413 views

Preparing for Winter: CDC Recommendations for Influenza, COVID-19, a…

Diego Hijano

2.0K views

Update on the New ANA Classification System

Keck School of Medicine of USC

E. Taylor-Albert

801 views

New

Project 2025 vs. the Public's Health Part II: The FDA

MicrobeTV

P. Offit, V. Racaniello

232 views

Points to Consider When Managing Inflammatory Arthritis with Cancer

RheumNow

J. Cush

223 views

Integrative Health Approaches for Optimum Immune Health

Cleveland Clinic Rheumatology

C. Wang

142 views

What's New with COVID in 2024?

Michigan Medicine

L. Washer

2.4K views

New

ACAAI 2024 Insights: Secondary Immunodeficiency - Management Strateg…

ACAAI 2024 Insights

S. Mustafa

75 views

ACR Convergence 2023 Highlights: People with RA and Long COVID Had…

RheumNow

R. Conway

46 views

Emergency Use Authorization for Updated COVID Vaccine, West Nile Vir…

MicrobeTV

D. Griffin, V. Racaniello

776 views

Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (AP…

West Virginia State Rheumatology Society

M. Petri

848 views

Vaccines for Adults: COVID, RSV, Influenza and More

Michigan Medicine

L. Washer

737 views

Durability of Protection Following Administration of Recombinant Ant…

MicrobeTV

D. Griffin, V. Racaniello

108 views

Disease Modifying Anti-rheumatic Drugs and Lymphoma Risk in Rheumato…

Namrata Singh

447 views

Project 2025 vs. The Public’s Health: What is Project 2025? What is …

MicrobeTV

P. Offit, V. Racaniello

244 views

AUTOPLAY

Login

Login

Join VuMedi

2021 Update on LN, RA & COVID-19: Is Voclosporin a New Big Addition to Lupus Treatment Arsenal? Are RA-ILD Patients at Higher Mortality Risk? Is Benlysta Therapy Safe With COVID-19 Vaccine?

Are your patients with moderate to severe Rheumatoid Arthritis (RA) …

Systemic Sclerosis-Associated Interstitial Lung Disease: A Patient&#…

Recommended

Long COVID & Post-Viral Syndromes ECHO Series 2025

RheumNow News Highlights: 11 Agents That Cause Arthritis, Lupus - Te…

Dermatology-Rheumatology Grand Rounds: The Whole Is Greater Than the…

Walking Pneumonia, the Beginning of Influenza Season, and Does Antiv…

Clinical Approach to Diagnosis and Treatment of Cytokine Storm in Rh…

What to Know About the FDA Authorization and Approval of Updated COV…

Checkpoint Inhibitors, Arthritis and Other Autoimmune Triggers

Preparing for Winter: CDC Recommendations for Influenza, COVID-19, a…

Update on the New ANA Classification System

Project 2025 vs. the Public's Health Part II: The FDA

Points to Consider When Managing Inflammatory Arthritis with Cancer

Integrative Health Approaches for Optimum Immune Health

What's New with COVID in 2024?

ACAAI 2024 Insights: Secondary Immunodeficiency - Management Strateg…

​​ACR Convergence 2023 Highlights: People with RA and Long COVID Had…

Emergency Use Authorization for Updated COVID Vaccine, West Nile Vir…

Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (AP…

Vaccines for Adults: COVID, RSV, Influenza and More

Durability of Protection Following Administration of Recombinant Ant…

Disease Modifying Anti-rheumatic Drugs and Lymphoma Risk in Rheumato…

Project 2025 vs. The Public’s Health: What is Project 2025? What is …

ACR Convergence 2023 Highlights: People with RA and Long COVID Had…